236 related articles for article (PubMed ID: 35968955)
61. Long-chain polyunsaturated fatty acids promote paclitaxel cytotoxicity via inhibition of the MDR1 gene in the human colon cancer Caco-2 cell line.
Kuan CY; Walker TH; Luo PG; Chen CF
J Am Coll Nutr; 2011 Aug; 30(4):265-73. PubMed ID: 21917707
[TBL] [Abstract][Full Text] [Related]
62. Comparative effects on intestinal absorption in situ by P-glycoprotein-modifying HIV protease inhibitors.
Richter M; Gyémánt N; Molnár J; Hilgeroth A
Pharm Res; 2004 Oct; 21(10):1862-6. PubMed ID: 15553233
[TBL] [Abstract][Full Text] [Related]
63. Intestinal absorption mechanisms of 2'-deoxy-2'-β-fluoro-4'-azidocytidine, a cytidine analog for AIDS treatment, and its interaction with P-glycoprotein, multidrug resistance-associated protein 2 and breast cancer resistance protein.
Liu Y; Liu B; Zhang Y; Peng Y; Huang C; Wang N; Jiang J; Wang Q; Chang J
Eur J Pharm Sci; 2017 Jul; 105():150-158. PubMed ID: 28487144
[TBL] [Abstract][Full Text] [Related]
64. Screening novel CNS drug candidates for P-glycoprotein interactions using the cell line iP-gp: In vitro efflux ratios from iP-gp and MDCK-MDR1 monolayers compared to brain distribution data from mice.
Ozgür B; Saaby L; Janfelt C; Langthaler K; Eneberg E; Jacobsen AM; Badolo L; Montanari D; Brodin B
Eur J Pharm Biopharm; 2021 Dec; 169():211-219. PubMed ID: 34756975
[TBL] [Abstract][Full Text] [Related]
65. JNK-AKT-NF-κB controls P-glycoprotein expression to attenuate the cytotoxicity of deoxynivalenol in mammalian cells.
Li X; Mu P; Qiao H; Wen J; Deng Y
Biochem Pharmacol; 2018 Oct; 156():120-134. PubMed ID: 30121250
[TBL] [Abstract][Full Text] [Related]
66. Novel application of rhein and its prodrug diacerein for reversing cancer-related multidrug resistance through the dual inhibition of P-glycoprotein efflux and STAT3-mediated P-glycoprotein expression.
Teng YN; Kao MC; Huang SY; Wu TS; Lee TE; Kuo CY; Hung CC
Biomed Pharmacother; 2022 Jun; 150():112995. PubMed ID: 35658243
[TBL] [Abstract][Full Text] [Related]
67. Role of P-glycoprotein in intestinal absorption of FB2, a promising Abl/Src dual tyrosine kinase inhibitor.
Huang K; Hu J; Li X; Li Y
Drug Metab Pharmacokinet; 2012; 27(5):486-94. PubMed ID: 22447116
[TBL] [Abstract][Full Text] [Related]
68. Regulation of P-glycoprotein by miR-27a-3p at the Brain Endothelial Barrier.
Hammad S; Mabondzo A; Hamoudi R; Harati R
J Pharm Sci; 2022 May; 111(5):1470-1479. PubMed ID: 34695419
[TBL] [Abstract][Full Text] [Related]
69. Down-regulation of intestinal scavenger receptor class B, type I (SR-BI) expression in rodents under conditions of deficient bile delivery to the intestine.
Voshol PJ; Schwarz M; Rigotti A; Krieger M; Groen AK; Kuipers F
Biochem J; 2001 Jun; 356(Pt 2):317-25. PubMed ID: 11368757
[TBL] [Abstract][Full Text] [Related]
70. P-glycoprotein expression in the gastrointestinal tract of male and female rats is influenced differently by food.
Dou L; Mai Y; Madla CM; Orlu M; Basit AW
Eur J Pharm Sci; 2018 Oct; 123():569-575. PubMed ID: 30118850
[TBL] [Abstract][Full Text] [Related]
71. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Lee TD; Lee OW; Brimacombe KR; Chen L; Guha R; Lusvarghi S; Tebase BG; Klumpp-Thomas C; Robey RW; Ambudkar SV; Shen M; Gottesman MM; Hall MD
Mol Pharmacol; 2019 Nov; 96(5):629-640. PubMed ID: 31515284
[TBL] [Abstract][Full Text] [Related]
72. Intestinal Farnesoid X Receptor Controls Transintestinal Cholesterol Excretion in Mice.
de Boer JF; Schonewille M; Boesjes M; Wolters H; Bloks VW; Bos T; van Dijk TH; Jurdzinski A; Boverhof R; Wolters JC; Kuivenhoven JA; van Deursen JM; Oude Elferink RPJ; Moschetta A; Kremoser C; Verkade HJ; Kuipers F; Groen AK
Gastroenterology; 2017 Apr; 152(5):1126-1138.e6. PubMed ID: 28065787
[TBL] [Abstract][Full Text] [Related]
73. PXR/CYP3A4-humanized mice for studying drug-drug interactions involving intestinal P-glycoprotein.
Holmstock N; Gonzalez FJ; Baes M; Annaert P; Augustijns P
Mol Pharm; 2013 Mar; 10(3):1056-62. PubMed ID: 23360470
[TBL] [Abstract][Full Text] [Related]
74. Age-related P-glycoprotein expression in the intestine and affecting the pharmacokinetics of orally administered enrofloxacin in broilers.
Guo M; Bughio S; Sun Y; Zhang Y; Dong L; Dai X; Wang L
PLoS One; 2013; 8(9):e74150. PubMed ID: 24066110
[TBL] [Abstract][Full Text] [Related]
75. Oleic acid increases uptake and decreases the P-gp-mediated efflux of the veterinary anthelmintic Ivermectin.
Houshaymi B; Nasreddine N; Kedees M; Soayfane Z
Drug Res (Stuttg); 2019 Feb; 69(3):173-180. PubMed ID: 30103215
[TBL] [Abstract][Full Text] [Related]
76. Possible involvement of multiple P-glycoprotein-mediated efflux systems in the transport of verapamil and other organic cations across rat intestine.
Saitoh H; Aungst BJ
Pharm Res; 1995 Sep; 12(9):1304-10. PubMed ID: 8570526
[TBL] [Abstract][Full Text] [Related]
77. Combined Omics Analysis Further Unveils the Specific Role of Butyrate in Promoting Growth in Early-Weaning Animals.
Zhang B; Liu M; Yue Z; Chen X; Li C; Liu L; Li F
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675302
[TBL] [Abstract][Full Text] [Related]
78. Comparative Hepatic and Intestinal Efflux Transport of Statins.
Deng F; Tuomi SK; Neuvonen M; Hirvensalo P; Kulju S; Wenzel C; Oswald S; Filppula AM; Niemi M
Drug Metab Dispos; 2021 Sep; 49(9):750-759. PubMed ID: 34162690
[TBL] [Abstract][Full Text] [Related]
79. Chitosan Influences the Expression of P-gp and Metabolism of Norfloxacin in Grass Carp.
Hu K; Xie X; Zhao YN; Li Y; Ruan J; Li HR; Jin T; Yang XL
J Aquat Anim Health; 2015 Jun; 27(2):104-11. PubMed ID: 25997556
[TBL] [Abstract][Full Text] [Related]
80. Fructose-induced metabolic syndrome decreases protein expression and activity of intestinal P-glycoprotein.
Novak A; Godoy YC; Martinez SA; Ghanem CI; Celuch SM
Nutrition; 2015 Jun; 31(6):871-6. PubMed ID: 25933496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
